Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Antioxidant Therapy in Proliferative Diabetic Retinopathy
NCT04071977Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Mar 2020
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Levels of oxidative stress markers in aqueous humor and vitreous humor at 2 months, Changes in concentration of plasma 8-isoprostanes at 2 months and 1 more. Started Mar 2020; status: completed.
Beyond the preview
Go deeper on NCT04071977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071977.